CN100531772C - 治疗肠易激综合征的中成药及其制备方法 - Google Patents
治疗肠易激综合征的中成药及其制备方法 Download PDFInfo
- Publication number
- CN100531772C CN100531772C CNB2006100543874A CN200610054387A CN100531772C CN 100531772 C CN100531772 C CN 100531772C CN B2006100543874 A CNB2006100543874 A CN B2006100543874A CN 200610054387 A CN200610054387 A CN 200610054387A CN 100531772 C CN100531772 C CN 100531772C
- Authority
- CN
- China
- Prior art keywords
- volatile oil
- hours
- decocting
- weight
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 120
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 208000011580 syndromic disease Diseases 0.000 title abstract description 3
- 210000000936 intestine Anatomy 0.000 title 1
- 239000008187 granular material Substances 0.000 claims abstract description 27
- 239000002775 capsule Substances 0.000 claims abstract description 9
- 239000000341 volatile oil Substances 0.000 claims description 140
- 239000002994 raw material Substances 0.000 claims description 76
- 239000000706 filtrate Substances 0.000 claims description 74
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 70
- 238000005303 weighing Methods 0.000 claims description 59
- 238000010438 heat treatment Methods 0.000 claims description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 52
- 239000000843 powder Substances 0.000 claims description 42
- 238000001914 filtration Methods 0.000 claims description 37
- 238000000605 extraction Methods 0.000 claims description 35
- 239000000203 mixture Substances 0.000 claims description 34
- 238000002156 mixing Methods 0.000 claims description 32
- 230000000694 effects Effects 0.000 claims description 31
- 239000007788 liquid Substances 0.000 claims description 31
- 208000002551 irritable bowel syndrome Diseases 0.000 claims description 30
- 238000001035 drying Methods 0.000 claims description 21
- 235000013599 spices Nutrition 0.000 claims description 21
- 230000006837 decompression Effects 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 18
- 238000009835 boiling Methods 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 238000004321 preservation Methods 0.000 claims description 15
- 238000001694 spray drying Methods 0.000 claims description 15
- 238000003860 storage Methods 0.000 claims description 15
- 239000004375 Dextrin Substances 0.000 claims description 13
- 229920001353 Dextrin Polymers 0.000 claims description 13
- 239000012141 concentrate Substances 0.000 claims description 12
- 235000019425 dextrin Nutrition 0.000 claims description 12
- 238000004821 distillation Methods 0.000 claims description 12
- 238000012856 packing Methods 0.000 claims description 12
- 239000006187 pill Substances 0.000 claims description 11
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 claims description 10
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 238000005507 spraying Methods 0.000 claims description 8
- 239000011230 binding agent Substances 0.000 claims description 6
- 229920000053 polysorbate 80 Polymers 0.000 claims description 4
- 239000008188 pellet Substances 0.000 claims description 3
- 238000005453 pelletization Methods 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000013355 food flavoring agent Nutrition 0.000 claims description 2
- 241000411851 herbal medicine Species 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 230000000968 intestinal effect Effects 0.000 abstract description 5
- 235000018645 Allium odorum Nutrition 0.000 abstract 1
- 244000003377 Allium tuberosum Species 0.000 abstract 1
- 235000005338 Allium tuberosum Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 206010022998 Irritability Diseases 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 239000013505 freshwater Substances 0.000 description 10
- 239000012467 final product Substances 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 125000003118 aryl group Chemical group 0.000 description 6
- 208000005392 Spasm Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010000059 abdominal discomfort Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000002075 main ingredient Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 2
- 229930003347 Atropine Natural products 0.000 description 2
- YWHLKYXPLRWGSE-UHFFFAOYSA-N Dimethyl trisulfide Chemical compound CSSSC YWHLKYXPLRWGSE-UHFFFAOYSA-N 0.000 description 2
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 201000009840 acute diarrhea Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 2
- 229960000396 atropine Drugs 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- -1 Compound Diphenoxylate Chemical class 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- XLBIBBZXLMYSFF-UHFFFAOYSA-M Propantheline bromide Chemical compound [Br-].C1=CC=C2C(C(=O)OCC[N+](C)(C(C)C)C(C)C)C3=CC=CC=C3OC2=C1 XLBIBBZXLMYSFF-UHFFFAOYSA-M 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- JUGOREOARAHOCO-UHFFFAOYSA-M acetylcholine chloride Chemical compound [Cl-].CC(=O)OCC[N+](C)(C)C JUGOREOARAHOCO-UHFFFAOYSA-M 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001004 anti-acetylcholinic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 229960004192 diphenoxylate Drugs 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 229960003684 oxedrine Drugs 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 229940099209 probanthine Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229930002600 steroidal saponin Natural products 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100543874A CN100531772C (zh) | 2006-06-25 | 2006-06-25 | 治疗肠易激综合征的中成药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100543874A CN100531772C (zh) | 2006-06-25 | 2006-06-25 | 治疗肠易激综合征的中成药及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101091770A CN101091770A (zh) | 2007-12-26 |
CN100531772C true CN100531772C (zh) | 2009-08-26 |
Family
ID=38990327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100543874A Active CN100531772C (zh) | 2006-06-25 | 2006-06-25 | 治疗肠易激综合征的中成药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100531772C (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102727628B (zh) * | 2012-06-15 | 2015-03-11 | 上海中医药大学附属岳阳中西医结合医院 | 一种用于脐疗治疗功能性便秘或腹泻的中药组合物 |
CN104306658B (zh) * | 2014-10-29 | 2016-06-15 | 重庆华森制药股份有限公司 | 一种痛泻宁颗粒的制备方法 |
CN111346193B (zh) * | 2019-08-12 | 2021-11-12 | 首都医科大学附属北京中医医院 | 预防和/或治疗腹泻型肠易激综合征的药物组合物及其制备方法和应用 |
CN111000230A (zh) * | 2019-11-25 | 2020-04-14 | 西安力邦制药有限公司 | 一种促进骨健康的组合物及应用 |
-
2006
- 2006-06-25 CN CNB2006100543874A patent/CN100531772C/zh active Active
Non-Patent Citations (2)
Title |
---|
《痛泻宁颗粒治疗腹泻型肠易激综合征(肝气乘脾证)的随机双盲安慰剂对照试验》. 王刚,李廷谦,王蕾,夏庆,陈雁,张瑞明.中国循证医学杂志,第6卷第2期. 2006 |
《痛泻宁颗粒治疗腹泻型肠易激综合征(肝气乘脾证)的随机双盲安慰剂对照试验》. 王刚,李廷谦,王蕾,夏庆,陈雁,张瑞明.中国循证医学杂志,第6卷第2期. 2006 * |
Also Published As
Publication number | Publication date |
---|---|
CN101091770A (zh) | 2007-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107536920A (zh) | 一种治疗周围神经炎的组合物、其制备方法和应用 | |
CN106421383A (zh) | 一种抗癌中药组合物 | |
CN102370687A (zh) | 一种治疗结肠炎的中药复方制剂及其制备方法 | |
CN100531772C (zh) | 治疗肠易激综合征的中成药及其制备方法 | |
CN101091778A (zh) | 一种治疗脾胃虚弱和消化不良的液体药物组合物及工艺 | |
CN101461932B (zh) | 一种治疗小儿脾虚湿热腹泻的药物组合物及其制备方法 | |
CN102657736B (zh) | 一种治疗类风湿性关节炎的药物组合物及其制备方法 | |
CN102600358A (zh) | 一种润肠通便的中药及其制品 | |
CN102210770A (zh) | 一种治疗痢疾的药物及其制备方法 | |
CN101530580B (zh) | 一种治疗溃疡性结肠炎的药物 | |
CN101850065B (zh) | 一种治疗痛风的中药组合物 | |
CN104257846A (zh) | 一种防治猪水肿病的中药组合物及其制备方法 | |
CN104083679A (zh) | 一种治疗胃肠疾病的中药组合物及其应用 | |
CN110870567B (zh) | 一种缓解痛风的食用颗粒及其制作方法 | |
CN102526211B (zh) | 一种治疗便秘口服药物的组方及制备工艺 | |
CN102188522A (zh) | 一种治疗便秘的中药组合物 | |
CN102210776A (zh) | 一种治疗感冒的药物及其制备方法 | |
CN101524447A (zh) | 一种治疗便秘的药物组合及其制备工艺 | |
CN102641413A (zh) | 一种治疗急性肠炎的药物及其制备方法 | |
CN101214302A (zh) | 一组治疗抑郁症伴生功能性消化不良的药物组合物及制法 | |
CN106215089A (zh) | 一种胃痛的中成药及其制备工艺 | |
CN102920917A (zh) | 一种治疗虚寒性胃脘痛的药物 | |
CN102247551A (zh) | 一种治疗便秘的药物 | |
CN1081044C (zh) | 一种治疗癌症的药物及其制备方法 | |
CN101991838A (zh) | 抗骨质增生、风湿、类风湿、椎间盘突出的组合药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Prepared Chinese medicine for treating intestine excitable syndrome and preparation method Effective date of registration: 20141120 Granted publication date: 20090826 Pledgee: Agricultural Bank of China Limited by Share Ltd. Chongqing Rongchang branch Pledgor: CHONGQING FORTUNE PHARMACEUTICAL CO.,LTD.|You Hongtao Registration number: 2014990000974 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20151222 Granted publication date: 20090826 Pledgee: Agricultural Bank of China Limited by Share Ltd. Chongqing Rongchang branch Pledgor: CHONGQING FORTUNE PHARMACEUTICAL CO.,LTD.|You Hongtao Registration number: 2014990000974 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 402460 Industrial Park, Rongchang District, Chongqing Patentee after: CHONGQING HUASEN PHARMACEUTICAL CO.,LTD. Address before: 402460 Rongchang Economic Development Zone, Chongqing Patentee before: CHONGQING FORTUNE PHARMACEUTICAL CO.,LTD. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Prepared Chinese medicine for treating intestine excitable syndrome and preparation method Effective date of registration: 20160321 Granted publication date: 20090826 Pledgee: Agricultural Bank of China Limited by Share Ltd. Chongqing Rongchang branch Pledgor: CHONGQING HUASEN PHARMACEUTICAL CO.,LTD. Registration number: 2016500000003 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170928 Granted publication date: 20090826 Pledgee: Agricultural Bank of China Limited by Share Ltd. Chongqing Rongchang branch Pledgor: CHONGQING HUASEN PHARMACEUTICAL CO.,LTD. Registration number: 2016500000003 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Prepared Chinese medicine for treating intestine excitable syndrome and preparation method Effective date of registration: 20180428 Granted publication date: 20090826 Pledgee: Agricultural Bank of China Limited by Share Ltd. Chongqing Rongchang branch Pledgor: CHONGQING HUASEN PHARMACEUTICAL CO.,LTD. Registration number: 2018980000058 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190725 Granted publication date: 20090826 Pledgee: Agricultural Bank of China Limited by Share Ltd. Chongqing Rongchang branch Pledgor: CHONGQING HUASEN PHARMACEUTICAL CO.,LTD. Registration number: 2018980000058 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chinese patent medicine for the treatment of irritable bowel syndrome and its preparation method Effective date of registration: 20230210 Granted publication date: 20090826 Pledgee: Agricultural Bank of China Limited by Share Ltd. Chongqing Rongchang branch Pledgor: CHONGQING HUASEN PHARMACEUTICAL CO.,LTD. Registration number: Y2023980032409 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20231229 Granted publication date: 20090826 Pledgee: Agricultural Bank of China Limited by Share Ltd. Chongqing Rongchang branch Pledgor: CHONGQING HUASEN PHARMACEUTICAL CO.,LTD. Registration number: Y2023980032409 |